Compounds > diethylstilbestrol

diethylstilbestrol and losartan

diethylstilbestrol has been researched along with losartan in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Kunert-Radek, J; Mucha, S; Pawlikowski, M; Pisarek, H; Sepien, H; Stawowy, A1
Grochal, M; Kulig, A; Kunert-Radek, J; Mucha, S; Pawllkowski, M; Stepień, H; Zieliński, K1
Kunert-Radek, J; Lawnicka, H; Mucha, S; Pawlikowski, M; Ptasinska-Wnuk, D; Stepien, H1

Reviews

1 review(s) available for diethylstilbestrol and losartan

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000

Other Studies

5 other study(ies) available for diethylstilbestrol and losartan

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Is estrogen-induced pituitary hyperplasia and hyperprolactinaemia mediated by angiotensin II?
    Advances in experimental medicine and biology, 1995, Volume: 377

    Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cell Division; Diethylstilbestrol; Enalapril; Enalaprilat; Estrogens; Estrogens, Non-Steroidal; Humans; Hyperpituitarism; Hyperplasia; Hyperprolactinemia; Imidazoles; Losartan; Prolactin; Pyridines; Rats; Rats, Inbred F344; Rats, Wistar; Tetrazoles; Tumor Cells, Cultured

1995
The effect of angiotensin II receptor antagonists on diethylstilbestrol-induced vascular changes in the rat anterior pituitary gland: a quantitative evaluation.
    Histology and histopathology, 1996, Volume: 11, Issue:4

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Diethylstilbestrol; Drug Implants; Imidazoles; Losartan; Male; Microcirculation; Pituitary Gland, Anterior; Pyridines; Rats; Rats, Inbred F344; Silicone Elastomers; Tetrazoles

1996
The involvement of angiotensin type 1 and type 2 receptors in estrogen-induced cell proliferation and vascular endothelial growth factor expression in the rat anterior pituitary.
    TheScientificWorldJournal, 2012, Volume: 2012

    Topics: Animals; Captopril; Cell Proliferation; Diethylstilbestrol; Estrogens; Gene Expression Regulation; Hyperplasia; Imidazoles; Immunohistochemistry; Losartan; Male; Neovascularization, Pathologic; Pituitary Gland, Anterior; Pyridines; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vascular Endothelial Growth Factor A

2012